December 1, 2016 - By Darrin Black · 0 Comments
The stock of Daxor Corporation (NYSEMKT:DXR) registered a decrease of 11.76% in short interest. DXR’s total short interest was 1,500 shares in December as published by FINRA. Its down 11.76% from 1,700 shares, reported previously. With 300 shares average volume, it will take short sellers 5 days to cover their DXR’s short positions. The short interest to Daxor Corporation’s float is 0.15%. About 20 shares traded hands. Daxor Corporation (NYSEMKT:DXR) has risen 5.46% since April 28, 2016 and is uptrending. It has underperformed by 0.47% the S&P500.
Daxor Corporation is an investment company with medical instrumentation and biotechnology operations. The company has a market cap of $31.41 million. The Firm engages in the short selling of stock. It currently has negative earnings. The Firm maintains a diversified securities portfolio, which consists primarily of the common and preferred stocks of electric utility companies.
Insitutional Activity: The institutional sentiment is 1 in Q2 2016. Its the same as in 2016Q1. The ratio is without change, as 2 funds sold all Daxor Corporation shares owned while 1 reduced positions. only 2 funds bought stakes while 1 increased positions. They now own 151,568 shares or 0.24% more from 151,208 shares in 2016Q1.
Vanguard Group holds 0% or 82,593 shares in its portfolio. The California-based Blackrock Fund Advisors has invested 0% in Daxor Corporation (NYSEMKT:DXR). California Public Employees Retirement Systems has 13,700 shares for 0% of their US portfolio. Moreover, Tower Rech Ltd Liability Com (Trc) has 0% invested in Daxor Corporation (NYSEMKT:DXR) for 1,290 shares. Moreover, Renaissance Limited Liability Com has 0% invested in Daxor Corporation (NYSEMKT:DXR) for 53,800 shares. Deutsche Bank & Trust Ag, a Germany-based fund reported 54 shares.
Daxor Corporation, incorporated on May 5, 1971, is an investment firm with medical instrumentation and biotechnology operations. The Firm engages in the short selling of stock. The Firm maintains a diversified securities portfolio, which consists primarily of the common and preferred stocks of electric utility companies. The Firm has approximately 70 Blood Volume Analyzers (BVA)-100. It also sells Volumex Kits. The Company’s IDANT division provides semen banking services, which include anonymous donor semen and semen storage; autologous blood storage; andrology services, which include semen analysis and sperm washing, and general lab testing.
More important recent Daxor Corporation (NYSEMKT:DXR) news were published by: Marketwired.com which released: “Daxor Corporation Announces Hiring of Chief Financial Officer” on June 17, 2016, also Marketwired.com published article titled: “Daxor Corporation Announces Filing of Form N-CSR for December 31, 2014”, Nypost.com published: “Sperm bank accused of discarding hazardous materials” on July 17, 2015. More interesting news about Daxor Corporation (NYSEMKT:DXR) was released by: Nasdaq.com and their article: “Weekly 3-Year Low Stocks: PBR, NJ, DWA, DXR” with publication date: February 11, 2013.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Darrin Black